Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pathway-based polygenic risk scores for schizophrenia and associations with clinical and neuroimaging phenotypes in UK Biobank

View ORCID ProfileMiruna C. Barbu, Gladi Thng, Mark J. Adams, Katie Marwick, View ORCID ProfileSeth GN Grant, View ORCID ProfileAndrew M. McIntosh, View ORCID ProfileStephen M. Lawrie, View ORCID ProfileHeather C. Whalley
doi: https://doi.org/10.1101/2022.07.12.22277553
Miruna C. Barbu
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miruna C. Barbu
  • For correspondence: mbarbu{at}ed.ac.uk
Gladi Thng
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Adams
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katie Marwick
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seth GN Grant
2Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seth GN Grant
Andrew M. McIntosh
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew M. McIntosh
Stephen M. Lawrie
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen M. Lawrie
Heather C. Whalley
1Division of Psychiatry, The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heather C. Whalley
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Schizophrenia is a heritable psychiatric disorder with a polygenic architecture. Genome-wide association studies (GWAS) have reported an increasing number of risk-associated variants and polygenic risk scores (PRS) now explain 17% of the variance in the disorder. There exists substantial heterogeneity in the effect of these variants and aggregating them based on biologically relevant functions may provide mechanistic insight into the disorder.

Methods Using the largest schizophrenia GWAS to date, we calculated PRS based on 5 gene-sets previously found to contribute to the pathophysiology of schizophrenia: the postsynaptic density of excitatory synapses, postsynaptic membrane, dendritic spine, axon, and histone H3-K4 methylation gene-sets. We associated each PRS, along with respective whole-genome PRS (excluding single nucleotide polymorphisms in each gene-set), with neuroimaging (N>29,000; cortical, subcortical, and white matter microstructure) and clinical (N>119,000; psychotic-like experiences including conspiracies, communications, voices, visions, and distress) variables in healthy subjects in UK Biobank.

Results A number of clinical and neuroimaging variables were significantly associated with the axon gene-set (psychotic-like communications: β=0.0916, pFDR=0.04, parahippocampal gyrus volume: β=0.0156, pFDR=0.03, FA thalamic radiations: β=-0.014, pFDR=0.036, FA posterior thalamic radiations: β=-0.016, pFDR=0.048), postsynaptic density gene-set (distress due to psychotic-like experiences: β=0.0588, pFDR=0.02, global surface area: β=-0.012, pFDR=0.034, and cingulate lobe surface area: β=-0.014, pFDR=0.04), and histone gene-set (entorhinal surface area: β=-0.016, pFDR=0.035). In the associations above, whole-genome PRS were significantly associated with psychotic-like communications (β=0.2218, pFDR =1.34×10−7), distress (β=0.1943, pFDR =7.28×10−16), and FA thalamic radiations (β=-0.0143, pFDR=0.036). Permutation analysis carried out for these associations revealed that they were not due to chance.

Conclusions Our results indicate that genetic variation in 3 gene-sets relevant to schizophrenia (axon, postsynaptic density, histone) may confer risk for the disorder through effects on a number of neuroimaging variables that have previously been implicated in schizophrenia. As neuroimaging associations were stronger for gene-set PRS than whole-genome PRS, findings here highlight that selection of biologically relevant variants may address the heterogeneity of the disorder by providing further mechanistic insight into schizophrenia.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was funded in whole, or in part, by the Wellcome Trust [216767/Z/19/Z]. This analysis uses linked data from UKB applications 4844 and 16124. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. MCB is supported by a Guarantors of Brain Non-clinical Post-Doctoral Fellowship and British Medical Association Margaret Temple Grant. HCW is supported by the Royal College of Physicians of Edinburgh (Sim Fellowship). MJA is supported by MRC Mental Health Data Pathfinder Award (MC_PC_17209). KM is supported by the Chief Scientist Office for Scotland and NHS Education for Scotland (PCL/17/01). This study is supported by a Wellcome Trust Strategic Award "Stratifying Resilience and Depression Longitudinally" (STRADL) (Reference 104036/Z/14/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK Biobank received ethical approval from the research ethics committee (REC reference 11/NW/0382), and this study has been approved by the UK Biobank Access Committee (Project No. 4844 and 16124).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵# Joint last author

  • Include additional information

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted July 19, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pathway-based polygenic risk scores for schizophrenia and associations with clinical and neuroimaging phenotypes in UK Biobank
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pathway-based polygenic risk scores for schizophrenia and associations with clinical and neuroimaging phenotypes in UK Biobank
Miruna C. Barbu, Gladi Thng, Mark J. Adams, Katie Marwick, Seth GN Grant, Andrew M. McIntosh, Stephen M. Lawrie, Heather C. Whalley
medRxiv 2022.07.12.22277553; doi: https://doi.org/10.1101/2022.07.12.22277553
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Pathway-based polygenic risk scores for schizophrenia and associations with clinical and neuroimaging phenotypes in UK Biobank
Miruna C. Barbu, Gladi Thng, Mark J. Adams, Katie Marwick, Seth GN Grant, Andrew M. McIntosh, Stephen M. Lawrie, Heather C. Whalley
medRxiv 2022.07.12.22277553; doi: https://doi.org/10.1101/2022.07.12.22277553

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)